288 related articles for article (PubMed ID: 26474358)
21. [Spontaneous bacterial peritonitis in the patients with liver cirrhosis].
Jarcuska P; Veselíny E; Orolín M; Takácová V; Hancová M
Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):265-70. PubMed ID: 15672324
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous bacterial peritonitis. Detection, treatment and prophylaxis in patients with liver cirrhosis.
Jansen PL
Neth J Med; 1997 Oct; 51(4):123-8. PubMed ID: 9446921
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous bacterial peritonitis.
Guarner C; Soriano G
Semin Liver Dis; 1997; 17(3):203-17. PubMed ID: 9308125
[TBL] [Abstract][Full Text] [Related]
24. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
Cullaro G; Kim G; Pereira MR; Brown RS; Verna EC
Dig Dis Sci; 2017 Dec; 62(12):3487-3494. PubMed ID: 29098551
[TBL] [Abstract][Full Text] [Related]
25. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
Reuken PA; Pletz MW; Baier M; Pfister W; Stallmach A; Bruns T
Aliment Pharmacol Ther; 2012 May; 35(10):1199-208. PubMed ID: 22449290
[TBL] [Abstract][Full Text] [Related]
26. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
27. Bacterascites: A study of clinical features, microbiological findings, and clinical significance.
Oey RC; van Buuren HR; de Jong DM; Erler NS; de Man RA
Liver Int; 2018 Dec; 38(12):2199-2209. PubMed ID: 29992711
[TBL] [Abstract][Full Text] [Related]
28. Clinical, laboratory and bacterial profile of Spontaneous Bacterial Peritonitis in Chronic Liver Disease patients.
Bibi S; Ahmed W; Arif A; Khan F; Alam SE
J Coll Physicians Surg Pak; 2015 Feb; 25(2):95-9. PubMed ID: 25703750
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.
Abd Elaal MM; Zaghloul SG; Bakr HG; Ashour MA; Abdel-Aziz-El-Hady H; Khalifa NA; Amr GE
Arab J Gastroenterol; 2012 Jun; 13(2):65-70. PubMed ID: 22980594
[TBL] [Abstract][Full Text] [Related]
30. [Spontaneous bacterial peritonitis].
Šenkeříková R; Fraňková S; Šperl J; Špičák J
Vnitr Lek; 2015 Feb; 61(2):134-40. PubMed ID: 25813257
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.
Kaymakoglu S; Eraksoy H; Okten A; Demir K; Calangu S; Cakaloglu Y; Boztas G; Besisik F
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):71-6. PubMed ID: 9031903
[TBL] [Abstract][Full Text] [Related]
32. Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis.
Ning NZ; Li T; Zhang JL; Qu F; Huang J; Liu X; Li Z; Geng W; Fu JL; Huan W; Zhang SY; Bao CM; Wang H
BMC Infect Dis; 2018 Jun; 18(1):253. PubMed ID: 29866104
[TBL] [Abstract][Full Text] [Related]
33. Management of uninfected and infected ascites in cirrhosis.
Solà E; Solé C; Ginès P
Liver Int; 2016 Jan; 36 Suppl 1():109-15. PubMed ID: 26725907
[TBL] [Abstract][Full Text] [Related]
34. Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: A randomized controlled trial.
Prakash V; Arora V; Jindal A; Maiwall R; Sarin SK
Liver Int; 2023 Jun; 43(6):1298-1306. PubMed ID: 36748109
[TBL] [Abstract][Full Text] [Related]
35. Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.
Fernández J; Acevedo J; Prado V; Mercado M; Castro M; Pavesi M; Arteaga M; Sastre L; Juanola A; Ginès P; Arroyo V
Liver Int; 2017 Mar; 37(3):385-395. PubMed ID: 27558198
[TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis of spontaneous bacterial peritonitis in liver cirrhosis].
Vinnitskaia EV; Osipov AG; Drozdov VN; Petrakov AV; Lazebnik LB
Eksp Klin Gastroenterol; 2008; (3):18-24. PubMed ID: 19145878
[TBL] [Abstract][Full Text] [Related]
38. [Spontaneous bacterial peritonitis: scientific and practical achievements and prospects].
Lazebnik LB; Vinnitskaia EV; Drozdov VN; Osipov GA; Petrakov AV
Eksp Klin Gastroenterol; 2011; (2):48-57. PubMed ID: 21563362
[TBL] [Abstract][Full Text] [Related]
39. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.
Chaulk J; Carbonneau M; Qamar H; Keough A; Chang HJ; Ma M; Kumar D; Tandon P
Can J Gastroenterol Hepatol; 2014 Feb; 28(2):83-8. PubMed ID: 24288693
[TBL] [Abstract][Full Text] [Related]
40. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis.
Mesquita MA; Balbino EP; Albuquerque RS; Carmona CA; Okubo BT; Lorena SL; Montes CG; Soares EC
Hepatogastroenterology; 1997; 44(17):1276-80. PubMed ID: 9356840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
